申请人:Reckitt & Colman Products Limited
公开号:US04241067A1
公开(公告)日:1980-12-23
Novel derivatives of morphine having the general formula: ##STR1## wherein R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are certain specified values, and their pharmaceutically acceptable salts. The compounds exhibit activity in the central nervous system and may be presented in the form of pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable salt thereof, in association with a pharmaceutically acceptable diluent or carrier.
形式为##STR1##的吗啡新衍生物,其中R.sup.2、R.sup.3、R.sup.4、R.sup.5和R.sup.6是特定的值,以及它们的药用盐。这些化合物在中枢神经系统中表现出活性,并可以以药物组合物的形式呈现,所述药物组合物包括公式(I)的化合物,或其药用可接受的盐,与药用可接受的稀释剂或载体结合。